John Gordon Freund Insider Trading $COLL COLLEGIUM PHARMACEUTICAL, INC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for John Gordon Freund.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of John Gordon Freund. John Gordon Freund is Director in XENOPORT INC ($XNPT) and See also footnote 4, 5 and 7 in XENOPORT INC ($XNPT) and Director in COLLEGIUM PHARMACEUTICAL, INC ($COLL) and Director in PROTEON THERAPEUTICS INC ($PRTO) and Director in TETRAPHASE PHARMACEUTICALS INC ($TTPH) and Director in SUTRO BIOPHARMA INC ($STRO) and in SI-BONE, Inc. ($SIBN) and Director in SI-BONE, Inc. ($SIBN).
John Gordon Freund in COLLEGIUM PHARMACEUTICAL, INC
Trading Symbol: COLLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of John Gordon Freund: Director
Holdings: 20,948 shares
Current Value: $321,761
Latest Transaction: May 24 2021
$COLL Market Capitalization: $351.67M
$COLL Previous Close: $15.36
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of John Gordon Freund in COLLEGIUM PHARMACEUTICAL, INC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, COLL, TARA, SIBN, STRO, TTPH, XNPT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2021 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 9,941 | 0 | 20,948 | 11 K to 20.9 K (+90.32 %) |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 22.05 | 8,095 | 178,495 | 8,095 | |
May 22 2020 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 4,047 | 0 | 11,007 | 7 K to 11 K (+58.15 %) |
Dec 04 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 8,625 | 0 | 8,625 | 0 to 8.6 K |
Dec 04 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 574,916 | 0 | 0 | 574.9 K to 0 (-100.00 %) |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 14.57 | 9,414 | 137,162 | 9,414 | |
Apr 29 2019 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 4,707 | 0 | 6,960 | 2.3 K to 7 K (+208.92 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 5,859 | 0 | 26,365 | 20.5 K to 26.4 K (+28.57 %) |
Nov 16 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 400,000 | 0 | 1,149,916 | 1.5 M to 1.1 M (-25.81 %) |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 24.95 | 4,506 | 112,425 | 4,506 | |
May 29 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Grant | A | 0.00 | 2,253 | 0 | 2,253 | 0 to 2.3 K |
Mar 21 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 8,791 | 0 | 20,506 | 11.7 K to 20.5 K (+75.04 %) |
Mar 21 2018 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 600,000 | 0 | 1,549,916 | 2.1 M to 1.5 M (-27.91 %) |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | J | 0.00 | 11,715 | 0 | 11,715 | 0 to 11.7 K |
Dec 07 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Sell | J | 0.00 | 800,000 | 0 | 2,149,916 | 2.9 M to 2.1 M (-27.12 %) |
May 25 2017 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 9.33 | 19,853 | 185,228 | 19,853 | |
Jun 13 2016 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 16.49 | 8,700 | 143,463 | 8,700 | |
Sep 14 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | A | 13.45 | 15,000 | 201,750 | 15,000 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 5,881,724 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 2,638,030 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Option Exercise | C | 0.00 | 10,714,286 | 0 | 0 | |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | P | 12.00 | 150,000 | 1,800,000 | 2,949,916 | 2.8 M to 2.9 M (+5.36 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 864,798 | 0 | 2,799,916 | 1.9 M to 2.8 M (+44.69 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 382,323 | 0 | 1,935,118 | 1.6 M to 1.9 M (+24.62 %) |
May 13 2015 | COLL | COLLEGIUM PHARMACE ... | Freund John Gordon | Director | Buy | C | 0.00 | 1,552,795 | 0 | 1,552,795 | 0 to 1.6 M |
Page: 1